June 21st 2024
An analysis from Harvard shows there is no significantly increased newborn risk when continuing metformin to treat type 2 diabetes in pregnant women.
2024 Neuromuscular Summit
November 20, 2024
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
PROLONG study contradicts earlier findings on 17-OHPC
November 6th 2019Although a 2003 clinical trial overwhelmingly found that 17-α-hydroxyprogesterone caproate (17-OHPC) significantly decreases recurrent preterm birth (PTB) and neonatal morbidity, a recently published study in the American Journal of Perinatology found drastically different results.
Read More